Commercial

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

With Gilead reporting that both of its approved CAR-Ts saw sales declines as other products saw growth, a mixture of different competitive headwinds seems to be behind the disparities.

European Commission approval positions Celltrion to streamline hospital workflows, with modelling suggesting millions in potential annual savings for healthcare systems.

Deal gives NTC exclusive rights to commercialize Formycon and Klinge’s Baiama aflibercept biosimilar in Italy, expanding Formycon’s growing network of European ophthalmology partners.

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

The biosimilar partnership between Samsung Bioepis and Biogen continues to crumble, with commercialization rights to Lucentis and Eylea biosimilars shifting hands now in Europe.

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.